Next-Generation Sequencing (NGS) Market

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024

Report Code: BT 2697 Aug, 2018, by marketsandmarkets.com

[228 Pages Report] The next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 4.83 billion in 2017, at a CAGR of 19.2% during the forecast period.

Years Considered for the Study

  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Period: 2018–2024

Market Dynamics

Drivers

Advancements in next-generation sequencing platforms

Continuous technological innovation in sequencers has enabled the introduction of effective, efficient, low-footprint/portable, and easy-to-use NGS platforms. Significant R&D has allowed for platforms that provide faster & accurate results and have increased applications and improved turnaround times.

Technological advancements provide an immediate competitive edge to players; as a result, prominent companies have ensured a consistent focus on product development and research to strengthen their market positions and shares. The iSeq system (Illumina) and Ion GeneStudio S5 systems (Thermo Fisher) are key revolutionary platforms launched in early 2018 that ensure high sequencing efficiency at a decreased cost. The development of these advanced platforms provides a competitive edge to players as they cannibalize the market share for similar lesser advanced products. Therefore, key players, as well as emerging players, are focused on continuous advancements to provide advanced sequencing technologies for various applications at a competitive price.

Restraints

End-user budget constraints in developing nations

Academic R&D in developing nations is mostly dependent on external funding. Despite continuous efforts by government and private bodies to provide funds for research across the globe, various research and academic institutes face budget constraints when it comes to the purchase and use of advanced and premium-priced equipment and technologies. As a result, the installation/expansion of advanced research facilities such as next-generation sequencing is hampered in academic and research institutes in developing nations. This is a key hindrance to market growth in developing nations across Africa and Asia.

Opportunities

Initiatives from government & private bodies for large-scale sequencing projects

Many countries are investing in their own national population sequencing programs to better understand the link between genetics and diseases. Under these initiatives, government organizations are sequencing millions of (citizens’) genomes to advance research and help develop better ways to diagnose and treat cancer, rare diseases, and other conditions. As a result, large sequencing projects can be expected to provide lucrative growth opportunities for market players, given the high-scale adoption of next-generation sequencing instruments and the use of consumables required in such efforts.

Objectives of the Study

  • To define, describe, and forecast the next-generation sequencing (NGS) market based on product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities) along with the current trends
  • To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total WGS market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for WGS market leaders
  • To forecast the revenue of the market segments with respect to four regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches & approvals; agreements, partnerships, and collaborations; acquisitions; and expansions in the market

Research Methodology

This research study involved the usage of extensive secondary sources, directories, and databases such as D&B, Bloomberg Business, and Factiva, along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the next-generation sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key sequencing market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various NGS players and professional associations.

Next-Generation Sequencing (NGS) Market

To get more details on this report, Download PDF Brochure

Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg) are the key players operating in the global advanced sequencing market. A majority of the leading players in next-generation DNA sequencing market are adopting the strategies of product launches and upgrades, partnerships and collaborations, and acquisitions to further enhance their market positions.

Stakeholders

  • NGS equipment manufacturers, vendors, and distributors
  • NGS sequencing service companies
  • NGS bioinformatics/data analysis companies
  • Research laboratories and academic institutes
  • Venture capitalists and other government funding organizations
  • Research and consulting firms
  • Healthcare institutions (hospitals and diagnostic clinics)
  • Pharmaceutical and biotechnology companies
  • Contract manufacturing organizations (CMOs)
  • Contract research organizations (CROs)

Scope of the Report

This research report categorizes the sequencing market into the following segments and subsegments:

Product & Service

  • Pre-sequencing Products and Services
    • DNA Fragmentation, End Repair, A-Tailing, and Size Selection
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Consumables
  • NGS Platforms
    • Illumina
      • Hiseq Series
      • Hiseq X Ten & HiSeq X Five
      • Miseq Series
      • NextSeq500
      • MiniSeq
      • NovaSeq
    • Thermo Fisher Scientific
      • Ion PGM
      • Ion Proton
      • Ion S5 & S5 XL
    • Pacific Biosciences
      • PacBio RS II
      • Sequel System
    • Oxford Nanopore Technologies
    • Other Next-generation Sequencing Platforms
  • Services for NGS Platforms
  • Sequencing Services
    • Exome & Targeted Sequencing and Custom Panels
    • RNA-Seq
    • Whole-genome Sequencing and De Novo Sequencing
    • Other Sequencing Services
  • Bioinformatics
    • NGS Data Analysis Software & Workbenches
    • NGS Data Analysis Services
    • NGS Storage Management and Cloud Computing Solutions

Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies

Application

  • Diagnostics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Other Diagnostic Applications
  • Drug Discovery
  • Agricultural and Animal Research
  • Other Applications&

End User

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Rest of the World (RoW)

*Note 1: Other disease diagnostic applications include rare genetic diseases and complex diseases.
Note 2: Other applications include marine research & research in biofuels, forensics, metagenomic studies, and evolutionary studies.
Note 3: Other end users include non-profit organizations (NPOs), agrigenomics organizations, reference laboratories, and consumer Genomics companies.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional next-generation DNA sequencing market players (up to 5)

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2% during the forecast period. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are expected to drive the growth of the next-generation DNA sequencing market.

The report analyzes the global advanced sequencing market, by product & service, technology, application, end user, and region.

On the basis of product & service, the WGS market is segmented into pre-sequencing products & services (DNA fragmentation, end repair, A-tailing, and size selection; library preparation & target enrichment; and quality control), NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics (NGS data analysis, storage, and management). The NGS platforms segment is further classified into Illumina (Hiseq Series, Hiseq X Ten & HiSeq X Five, Miseq Series, NextSeq 500, MiniSeq, and NovaSeq), Thermo Fisher Scientific (Ion PGM, Ion Proton, and Ion S5 & S5 XL), Pacific Biosciences (PacBio RS II and Sequel system), Oxford Nanopore Technologies, and Other Next-generation Sequencing Platforms. The NGS consumables segment is expected to account for the largest share of the next-generation sequencing market in 2018. Advancements in sequencing technologies, growing number of sequencing procedures, and launch of easy-to-use consumables are the key factors driving the growth of the consumables segment.

Based on end user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these, the academic institutes & research centers segment is expected to account for the largest share of the market in 2018, owing to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomic research across regions, and the development of cost-efficient NGS products and services for researchers.

This report covers the WGS market in North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), and the Rest of the World (RoW). North America is expected to account for the largest share of the global advanced sequencing market in 2018, followed by Europe. The large share of North America is mainly attributed to the increasing application of NGS in diagnostics and genomics research, availability of research funding, and development of NGS data analysis solutions.

Next-Generation Sequencing (NGS) Market

To get more details on this report, Request FREE Sample

As of 2017, Illumina (US) dominated the global WGS market through its broad product portfolio, strong geographical presence, and wide customer base across the globe. To maintain its leadership position in the WGS market, the company has been focusing on technological advancements in the field of sequencing. Thermo Fisher Scientific (US) held the second position in the global next-generation sequencing market. Other prominent players in this market include Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Advanced Sequencing Market Definition
    1.3 next-generation DNA sequencing market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 WGS Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Second Generation Sequencing Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 35)
    4.1 Next-Generation Sequencing (NGS): Market Overview
    4.2 NGS Market, By Product & Service, 2018 vs 2024
    4.3 Advanced Sequencing Market, By Technology, 2018 vs 2024 (USD Million)
    4.4 NGS Market, By Application, 2018 vs 2024 (USD Million)
    4.5 Next-generation DNA Sequencing Market, By End User and Region, 2018

5 Full Genome Sequencing Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Second Generation Sequencing Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Advancements in NGS Platforms
                               5.2.1.1.1 ISEQ
                               5.2.1.1.2 Ion Genestudio S5
                    5.2.1.2 Declining Costs
                    5.2.1.3 Improving Regulatory & Reimbursement Scenario for NGS-Based Diagnostic Tests
           5.2.2 Restraints
                    5.2.2.1 End-User Budget Constraints in Developing Nations
           5.2.3 Opportunities
                    5.2.3.1 Initiatives From Government & Private Bodies for Large-Scale Sequencing Projects
                    5.2.3.2 Application of NGS in Precision Medicine & Molecular Diagnostics
                    5.2.3.3 NGS Data Analysis Using Big Data
           5.2.4 Challenges
                    5.2.4.1 Interpretation of Complex Data From NGS Platforms
                    5.2.4.2 Ethical Issues
           5.2.5 Industry Trends
                    5.2.5.1 Reduction in Platform Footprint and the Development of Portable Sequencing Technology
                    5.2.5.2 Partnerships and Collaborations for Technological Advancements in NGS
                    5.2.5.3 Conferences and Workshops Increasing Awareness on NGS Products and Services

6 Next-Generation Sequencing Market, By Product & Service (Page No. - 47)
    6.1 Introduction
    6.2 Pre-Sequencing Products & Services
           6.2.1 Sample Preparation
                    6.2.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
                    6.2.1.2 Library Preparation & Target Enrichment
                    6.2.1.3 Quality Control
    6.3 NGS Consumables, Platforms, & Services for Platforms
           6.3.1 NGS Consumables
           6.3.2 NGS Platforms
                    6.3.2.1 Illumina
                               6.3.2.1.1 Hiseq Series
                               6.3.2.1.2 Hiseq X Ten & Hiseq X Five
                               6.3.2.1.3 Miseq Series
                               6.3.2.1.4 Nextseq 500
                               6.3.2.1.5 Miniseq
                               6.3.2.1.6 Novaseq
                    6.3.2.2 Thermo Fisher Scientific
                               6.3.2.2.1 Ion PGM
                               6.3.2.2.2 Ion Proton
                               6.3.2.2.3 Ion S5 & S5 XL
                    6.3.2.3 Pacific Biosciences
                               6.3.2.3.1 Pacbio RS II
                               6.3.2.3.2 Sequel System
                    6.3.2.4 Oxford Nanopore Technologies
                    6.3.2.5 Other Next-Generation Sequencing Platforms
           6.3.3 Services for NGS Platforms
    6.4 Sequencing Services
           6.4.1 Exome & Targeted Re-Sequencing and Custom Panels
           6.4.2 RNA-Seq
           6.4.3 Whole-Genome Sequencing & De Novo Sequencing
           6.4.4 Other Sequencing Services
    6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
           6.5.1 NGS Data Analysis Software & Workbenches
           6.5.2 NGS Data Analysis Services
           6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Next-Generation Sequencing Market, By Technology (Page No. - 78)
    7.1 Introduction
    7.2 Sequencing By Synthesis
    7.3 Ion Semiconductor Sequencing
    7.4 Single-Molecule Real-Time Sequencing
    7.5 Nanopore Sequencing
    7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application (Page No. - 86)
    8.1 Introduction
    8.2 Diagnostics
           8.2.1 Cancer Diagnostics
           8.2.2 Infectious Disease Diagnostics
           8.2.3 Reproductive Health Diagnostics
           8.2.4 Other Diagnostic Applications
    8.3 Drug Discovery
    8.4 Agricultural & Animal Research
    8.5 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. - 98)
    9.1 Introduction
    9.2 Academic Institutes & Research Centers
    9.3 Hospitals & Clinics
    9.4 Pharmaceutical & Biotechnology Companies
    9.5 Other End Users

10 Next-Generation Sequencing Market, By Region (Page No. - 105)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 UK
             10.3.3 France
             10.3.4 Spain
             10.3.5 Italy
             10.3.6 Netherlands
             10.3.7 RoE
     10.4 Asia Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 146)
     11.1 Overview
     11.2 Full Genome Sequencing Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Product Launches, Product Enhancements, and Service Launches
             11.3.2 Agreements, Partnerships, Collaborations, and Contracts
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions

12 Company Profile (Page No. - 153)
     12.1 10x Genomics
             12.1.1 Business Overview
             12.1.2 Products Offered
             12.1.3 Recent Developments (2015-2018)
             12.1.4 MnM View
     12.2 Agilent Technologies, Inc.
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Developments (2015-2018)
             12.2.4 MnM View
     12.3 Beckman Coulter (A Subsidiary of Danaher)
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Developments (2015-2018)
             12.3.4 MnM View
     12.4 Becton, Dickinson and Company
             12.4.1 Business Overview
             12.4.2 Products Offered
             12.4.3 Recent Developments (2015-2018)
             12.4.4 MnM View
     12.5 BGI
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Services Offered
             12.5.4 MnM View
     12.6 Eurofins Scientific
             12.6.1 Business Overview
             12.6.2 Services Offered
             12.6.3 Recent Developments (2015-2018)
             12.6.4 MnM View
     12.7 F. Hoffmann-La Roche AG
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Developments (2015-2018)
             12.7.4 MnM View
     12.8 Genewiz
             12.8.1 Business Overview
             12.8.2 Services Offered
             12.8.3 Recent Developments (2015-2018)
             12.8.4 MnM View
     12.9 Illumina, Inc.
             12.9.1 Business Overview
             12.9.2 Products Offered
             12.9.3 Services Offered
             12.9.4 Recent Developments (2015-2018)
             12.9.5 MnM View
     12.10 Macrogen, Inc.
             12.10.1 Business Overview
             12.10.2 Services Offered
             12.10.3 Recent Developments (2015-2018)
             12.10.4 MnM View
     12.11 Oxford Nanopore Technologies, Ltd.
             12.11.1 Business Overview
             12.11.2 Products Offered
             12.11.3 Recent Developments (2015-2018)
             12.11.4 MnM View
     12.12 Pacific Biosciences of California, Inc.
             12.12.1 Business Overview
             12.12.2 Products Offered
             12.12.3 Services Offered
             12.12.4 Recent Developments (2015-2018)
             12.12.5 MnM View
     12.13 Perkinelmer, Inc.
             12.13.1 Business Overview
             12.13.2 Products & Services Offered
             12.13.3 Recent Developments (2015-2018)
             12.13.4 MnM View
     12.14 Thermo Fisher Scientific Inc.
             12.14.1 Business Overview
             12.14.2 Products and Services Offered
             12.14.3 Recent Developments (2015-2018)
             12.14.4 MnM View
     12.15 Qiagen N.V.
             12.15.1 Business Overview
             12.15.2 Products & Services Offered
             12.15.3 Recent Developments (2015-2018)
             12.15.4 MnM View

13 Appendix (Page No. - 219)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (109 Tables)

Table 1 Advanced Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 2 Pre-Sequencing Products & Services Market, By Region, 2016–2024 (USD Million)
Table 3 NGS Sample Preparation Market, By Type, 2016–2024 (USD Million)
Table 4 Dna Fragmentation, End Repair, A-Tailing, & Size Selection Market, By Region, 2016–2024 (USD Million)
Table 5 Library Preparation & Target Enrichment Market, By Region, 2016–2024 (USD Million)
Table 6 Quality Control Market, By Region, 2016–2024 (USD Million)
Table 7 NGS Platforms, Consumables, and Services for Platforms Market, By Type, 2016–2024 (USD Million)
Table 8 NGS Consumables Market, By Region, 2016–2024 (USD Million)
Table 9 NGS Platforms Market, By Type, 2016–2024 (USD Million)
Table 10 NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 11 Illumina NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 12 Illumina NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 13 Hiseq Series Platforms Market, By Region, 2016–2024 (USD Million)
Table 14 Hiseq X Ten & Hiseq X Five Platforms Market, By Region, 2016–2024 (USD Million)
Table 15 Miseq Series Platforms Market, By Region, 2016–2024 (USD Million)
Table 16 Nextseq 500 Platforms Market, By Region, 2016–2024 (USD Million)
Table 17 Miniseq Platforms Market, By Region, 2016–2024 (USD Million)
Table 18 Novaseq Platforms Market, By Region, 2016–2024 (USD Million)
Table 19 Thermo Fisher Scientific NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 20 Thermo Fisher Scientific NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 21 Ion PGM Platforms Market, By Region, 2016–2024 (USD Million)
Table 22 Ion Proton Platforms Market, By Region, 2016–2024 (USD Million)
Table 23 Ion S5 & S5 XL Platforms Market, By Region, 2016–2024 (USD Million)
Table 24 Pacific Biosciences NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 25 Pacific Biosciences NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 26 Pacbio RS II Platforms Market, By Region, 2016–2024 (USD Million)
Table 27 Sequel System Market, By Region, 2016–2024 (USD Million)
Table 28 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 29 Other NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 30 Services for NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 31 Sequencing Services Market, By Type, 2016–2024 (USD Million)
Table 32 Sequencing Services Market, By Region, 2016–2024 (USD Million)
Table 33 NGS Bioinformatics Market, By Product & Service, 2016–2024 (USD Million)
Table 34 NGS Bioinformatics Market, By Region, 2016–2024 (USD Million)
Table 35 Next-Generation Sequencing Technologies, By Company
Table 36 Global Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 37 Sequencing By Synthesis Market, By Region, 2016–2024 (USD Million)
Table 38 Ion Semiconductor Sequencing Market, By Region, 2016–2024 (USD Million)
Table 39 Single-Molecule Real-Time Sequencing Market, By Region, 2016–2024 (USD Million)
Table 40 Nanopore Sequencing Market, By Region, 2016–2024 (USD Million)
Table 41 Other Sequencing Technologies, By Region, 2016–2024 (USD Million)
Table 42 Sequencing Market, By Application, 2016–2024 (USD Million)
Table 43 Full Genome Sequencing Market for Diagnostics, By Type, 2016–2024 (USD Million)
Table 44 Next-generation DNA Sequencing Market for Diagnostics, By Region, 2016–2024 (USD Million)
Table 45 Advanced Sequencing Market fr Drug Discovery, By Region, 2016–2024 (USD Million)
Table 46 Second Generation Sequencing Market for Agricultural and Animal Research, By Region, 2016–2024 (USD Million)
Table 47 Full Genome Sequencing Market for Other Applications, By Region, 2016–2024 (USD Million)
Table 48 Sequencing Market, By End User, 2016–2024 (USD Million)
Table 49 Next-generation DNA Sequencing Market for Academic Institutes & Research Centers, By Region, 2016–2024 (USD Million)
Table 50 Global Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2016–2024 (USD Million)
Table 51 Whole Genome Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2024 (USD Million)
Table 52 Second Generation Sequencing Market for Other End Users, By Region, 2016–2024 (USD Million)
Table 53 Advanced Sequencing Market, By Region, 2016–2024 (USD Million)
Table 54 North America: WGS Market, By Country, 2016–2024 (USD Million)
Table 55 North America: WGS Market, By Product & Service, 2016–2024 (USD Million)
Table 56 North America: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 57 North America: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 58 North America: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 59 North America: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 60 North America: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 61 North America: Whole Genome Sequencing Market , By Technology, 2016–2024 (USD Million)
Table 62 North America: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 63 North America: Whole Genome Sequencing Market , By End User, 2016–2024 (USD Million)
Table 64 US: Next-generation DNA Sequencing Market, By Application, 2016–2024 (USD Million)
Table 65 Canada: Full Genome Sequencing Market , By Application, 2016–2024 (USD Million)
Table 66 Europe: Global Next-Generation Sequencing Market, By Country, 2016–2024 (USD Million)
Table 67 Europe: Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 68 Europe: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 69 Europe: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 70 Europe: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 71 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 72 Europe: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 73 Europe: Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 74 Europe: Whole Genome Sequencing Market , By Application, 2016–2024 (USD Million)
Table 75 Europe: Second Generation Sequencing Market , By End User, 2016–2024 (USD Million)
Table 76 Germany: Global Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 77 UK: Full Genome Sequencing Market , By Application, 2016–2024 (USD Million)
Table 78 France: WGS Market, By Application, 2016–2024 (USD Million)
Table 79 Spain: Whole Genome Sequencing Market , By Application, 2016–2024 (USD Million)
Table 80 Italy: Sequencing Market, By Application, 2016–2024 (USD Million)
Table 81 Netherlands: WGS Market, By Application, 2016–2024 (USD Million)
Table 82 RoE: WGS Market, By Application, 2016–2024 (USD Million)
Table 83 Asia Pacific: WGS Market, By Country, 2016–2024 (USD Million)
Table 84 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 85 Asia Pacific: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 86 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 87 Asia Pacific: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 88 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 89 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 90 Asia Pacific: Advanced Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 91 Asia Pacific: Full Genome Sequencing Market , By Application, 2016–2024 (USD Million)
Table 92 Asia Pacific: Whole Genome Sequencing Market , By End User, 2016–2024 (USD Million)
Table 93 China: Global Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 94 Japan: Second Generation Sequencing Market , By Application, 2016–2024 (USD Million)
Table 95 India: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 96 RoAPAC: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 97 RoW: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 98 RoW: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 99 RoW: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 100 RoW: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 101 RoW: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 102 RoW: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 103 RoW: Global Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 104 RoW: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 105 RoW: Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 106 Key Launches, Product Enhancements, and Service Launches 2017–2018 (July)
Table 107 Key Five Agreements, Partnerships, Collaborations, and Contracts, 2017–2018 (July)
Table 108 Key Mergers and Acquisitions, 2017–2018 (July)
Table 109 Key Geographic Expansions, 2017–2018 (July)


List of Figures (44 Figures)

Figure 1 Global Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Sequencing Market: Bottom-Up Approach
Figure 5 NGS Platforms Market: Bottom-Up Approach
Figure 6 WGS Market: Top-Down Approach
Figure 7 Second Generation Sequencing Market : Data Triangulation
Figure 8 Next-Generation Sequencing Market, By Application, 2018 vs 2024 (USD Million)
Figure 9 Next-Generation Sequencing Market, By Product & Service, 2018 vs 2024 (USD Million)
Figure 10 Next-Generation Sequencing Market, By Technology, 2018 vs 2024 (USD Million)
Figure 11 Global Next-Generation Sequencing Market, By End User, 2018 vs 2024 (USD Million)
Figure 12 Geographic Snapshot: Next-Generation Sequencing Market
Figure 13 Full Genome Sequencing Market is Expected to Register A Double-Digit Growth Rate
Figure 14 Consumables Segment is Expected to Account for the Major Share During Forecast Period
Figure 15 Sequencing By Synthesis Segment to Dominate the Market in 2024
Figure 16 Diagnostics Segment is Expected to Grow at the Highest Rate During the Study Period
Figure 17 Academic Institutes and Research Centers Segment to Account for the Largest Share of the Market
Figure 18 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Cost of Human Whole-Genome Sequencing, 2001–2017
Figure 20 Comparison of System/Platform Costs, By Company
Figure 21 Consumables Segment to Dominate the Next-Generation Sequencing Market in 2018
Figure 22 Nanopore Sequencing is Expected to Register the Highest CAGR During the Forecast Period (2018 to 2024)
Figure 23 Diagnostics Segment Will Continue to Dominate the Next-Generation Sequencing Applications Market Till 2024
Figure 24 Cancer Diagnostics to Dominate the Next-Generation Sequencing Diagnostic Applications Market Till 2024
Figure 25 Funding for Cancer Research From the National Cancer Institute (2016)
Figure 26 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017
Figure 27 Hospitals & Clinics Segment is Expected to Grow at the Highest Rate During the Study Period
Figure 28 North America: Next-Generation Sequencing Market Snapshot
Figure 29 Europe: Next-Generation Sequencing Market Snapshot
Figure 30 Asia Pacific: Next-Generation Sequencing Market Snapshot
Figure 31 RoW: Next-Generation Sequencing Market Snapshot
Figure 32 Key Developments in the Next-Generation Sequencing Market, Jan 2015 to July 2018
Figure 33 Next-Generation Sequencing Market Share Analysis, By Key Player, 2017
Figure 34 Next-Generation Sequencing Platform Market Share Analysis, By Key Player, 2017
Figure 35 Agilent Technologies: Company Snapshot (2017)
Figure 36 Danaher Corporation: Company Snapshot (2017)
Figure 37 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 38 Eurofins Scientific: Company Snapshot (2017)
Figure 39 Roche: Company Snapshot (2017)
Figure 40 Illumina: Company Snapshot (2017)
Figure 41 Pacific Biosciences of California: Company Snapshot (2017)
Figure 42 Perkinelmer, Inc.: Company Snapshot (2017)
Figure 43 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 44 Qiagen N.V.: Company Snapshot (2017)

To get more details on this report, Request FREE Sample


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2697
Published ON
Aug, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Next-Generation Sequencing (NGS) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home